{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T16:31:16Z","timestamp":1790958676285,"version":"4.1.0"},"update-to":[{"DOI":"10.1002\/14651858.cd001211.pub2","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2012,9,12]],"date-time":"2012-09-12T00:00:00Z","timestamp":1347408000000}}],"reference-count":47,"publisher":"Wiley","content-domain":{"domain":["wiley.com","cochranelibrary.com"],"crossmark-restriction":true},"short-container-title":[],"DOI":"10.1002\/14651858.cd001211.pub3","type":"journal-article","created":{"date-parts":[[2012,9,4]],"date-time":"2012-09-04T22:00:57Z","timestamp":1346796057000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":41,"title":["Antibiotics versus placebo for acute bacterial conjunctivitis"],"prefix":"10.1002","author":[{"given":"Aziz","family":"Sheikh","sequence":"first","affiliation":[{"name":"The University of Edinburgh; Centre for Population Health Sciences; Medical School Doorway 3, Teviot Place Edinburgh UK EH8 9AG"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian","family":"Hurwitz","sequence":"additional","affiliation":[{"name":"King's College London; Department of English Strand London UK WC2R 2LS"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Constant Paul","family":"van Schayck","sequence":"additional","affiliation":[{"name":"Maastricht University; Department of General Practice; P Debyeplein 1, PO Box 616 Maastricht Netherlands 6200 MD"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susannah","family":"McLean","sequence":"additional","affiliation":[{"name":"The University of Edinburgh; Allergy & Respiratory Research Group, Centre for Population Health Sciences; Doorway 1 Teviot Place Edinburgh Scotland UK EH8 9AG"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ulugbek","family":"Nurmatov","sequence":"additional","affiliation":[{"name":"Centre for Population Health Sciences, The University of Edinburgh; Allergy & Respiratory Research Group; 20 West Richmond Street Edinburgh UK EH8 9DX"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2012,9,12]]},"reference":[{"key":"10.1002\/14651858.CD001211.pub3-BIB0001|cit1","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1016\/j.ajo.2008.01.019","article-title":"Clinical cure of bacterial conjunctivitis with azithromycin 1%: vehicle-controlled, double-masked clinical trial","volume":"145","author":"Abelson","year":"2008","journal-title":"American Journal of Ophthalmology"},{"key":"10.1002\/14651858.CD001211.pub3-BIB0002|cit2","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1016\/S0022-3476(84)80566-1","article-title":"Efficacy of topical antibiotic therapy in acute conjunctivitis in children","volume":"104","author":"Gigliotti","year":"1984","journal-title":"Journal of Pediatrics"},{"issue":"2","key":"10.1002\/14651858.CD001211.pub3-BIB0003|cit3","first-page":"227","article-title":"Early clinical and microbiological responses in the treatment of bacterial conjunctivitis with moxifloxacin ophthalmic solution 0.5% (Vigamox TM) using b.i.d dosing","volume":"21","author":"Gross","year":"2003","journal-title":"Today's Therapeutic Trends"},{"issue":"3","key":"10.1002\/14651858.CD001211.pub3-BIB0004|cit4","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1016\/j.clinthera.2009.03.010","article-title":"Besifloxacin ophthalmic suspension 0.6% in patients with bacterial conjunctivitis: a multicenter, prospective, randomized, double-masked, vehicle-controlled, 5-day efficacy and safety study","volume":"31","author":"Karpecki","year":"2009","journal-title":"Clinical Therapeutics"},{"key":"10.1002\/14651858.CD001211.pub3-BIB0005|cit5","first-page":"29S","article-title":"Antibacterial effectiveness of ciprofloxacin 0.3% ophthalmic solution in the treatment of bacterial conjunctivitis","volume":"112","author":"Leibowitz","year":"1991","journal-title":"American Journal of Ophthalmology"},{"key":"10.1002\/14651858.CD001211.pub3-BIB0006|cit6","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1177\/112067219200200202","article-title":"The safety and efficacy of topical norfloxacin compared with placebo in the treatment of acute, bacterial conjunctivitis","volume":"2","author":"Miller","year":"1992","journal-title":"European Journal of Ophthalmology"},{"key":"10.1002\/14651858.CD001211.pub3-BIB0007|cit7","first-page":"924","article-title":"The treatment of acute infectious conjunctivitis with fusidic acid: a randomised controlled trial","volume":"55","author":"Rietveld","year":"2005","journal-title":"British Journal of General Practice"},{"key":"10.1002\/14651858.CD001211.pub3-BIB0008|cit8","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/S0140-6736(05)66709-8","article-title":"Chloramphenicol treatment for acute infective conjunctivitis in children in primary care: a randomised double-blind placebo-controlled trial","volume":"366","author":"Rose","year":"2005","journal-title":"Lancet"},{"issue":"1","key":"10.1002\/14651858.CD001211.pub3-BIB0009|cit9","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.clinthera.2010.12.004","article-title":"Efficacy and tolerability of besifloxacin ophthalmic suspension 0.6% administered twice daily for 3 days in the treatment of bacterial conjunctivitis: a multicenter, randomized, double-masked, vehicle-controlled, parallel-group study in adults and children","volume":"33","author":"Silverstein","year":"2011","journal-title":"Clinical Therapeutics"},{"issue":"7","key":"10.1002\/14651858.CD001211.pub3-BIB0010|cit10","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1007\/s12325-011-0037-x","article-title":"Microbiological efficacy of a new ophthalmic formulation of moxifloxacin dosed twice-daily for bacterial conjunctivitis","volume":"28","author":"Tauber","year":"2011","journal-title":"Advances in Therapy"},{"issue":"5","key":"10.1002\/14651858.CD001211.pub3-BIB0011|cit11","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1185\/03007990902837919","article-title":"Phase III efficacy and safety study of besifloxacin ophthalmic suspension 0.6% in the treatment of bacterial conjunctivitis","volume":"25","author":"Tepedino","year":"2009","journal-title":"Current Medical Research and Opinion"},{"issue":"3","key":"10.1002\/14651858.CD001211.pub3-BIB0012|cit12","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1097\/INF.0b013e3181b99fa2","article-title":"Efficacy and safety of azithromycin 1.5% eye drops for purulent bacterial conjunctivitis in pediatric patients","volume":"29","author":"Bremond-Gignac","year":"2010","journal-title":"Pediatric Infectious Disease Journal"},{"issue":"6","key":"10.1002\/14651858.CD001211.pub3-BIB0013|cit13","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1177\/112067210801800602","article-title":"Microbiological efficacy of 3-day treatment with azithromycin 1.5% eye-drops for purulent bacterial conjunctivitis","volume":"18","author":"Denis","year":"2008","journal-title":"European Journal of Ophthalmology"},{"issue":"7563","key":"10.1002\/14651858.CD001211.pub3-BIB0014|cit14","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1136\/bmj.38891.551088.7C","article-title":"A randomised controlled trial of management strategies for acute infective conjunctivitis in general practice","volume":"333","author":"Everitt","year":"2006","journal-title":"BMJ"},{"issue":"6","key":"10.1002\/14651858.CD001211.pub3-BIB0015|cit15","doi-asserted-by":"crossref","first-page":"340","DOI":"10.3928\/01913913-20081101-07","article-title":"A multicenter comparison of polymyxin B sulfate\/trimethoprim ophthalmic solution and moxifloxacin in the speed of clinical efficacy for the treatment of bacterial conjunctivitis","volume":"45","author":"Granet","year":"2008","journal-title":"Journal of Pediatric Ophthalmology and Strabismus"},{"key":"10.1002\/14651858.CD001211.pub3-BIB0016|cit16","doi-asserted-by":"crossref","first-page":"1752","DOI":"10.1001\/archopht.1976.03910040526011","article-title":"Human conjunctivitis. II. Treatment","volume":"94","author":"Leibowitz","year":"1976","journal-title":"Archives of Ophthalmology"},{"issue":"9","key":"10.1002\/14651858.CD001211.pub3-BIB0017|cit17","doi-asserted-by":"crossref","first-page":"1615","DOI":"10.1016\/j.ophtha.2009.05.014","article-title":"Efficacy and safety of besifloxacin ophthalmic suspension 0.6% compared with moxifloxacin ophthalmic solution 0.5% for treating bacterial conjunctivitis","volume":"116","author":"McDonald","year":"2009","journal-title":"Ophthalmology"},{"key":"10.1002\/14651858.CD001211.pub3-BIB0018|cit18","first-page":"1813","article-title":"Therapeutic effects of ofloxacin eye drops (DE-055) on external infection of the eye: multicentral double blind test","volume":"80","author":"Mitsui","year":"1986","journal-title":"Japanese Review of Clinical Ophthalmology"},{"issue":"4","key":"10.1002\/14651858.CD001211.pub3-BIB0019|cit19","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/j.jfo.2010.01.005","article-title":"Efficacy assessment of azithromycin 1.5% eye drops versus tobramycin 0.3% on clinical signs of purulent bacterial conjunctivitis","volume":"33","author":"Robert","year":"2010","journal-title":"Journal Fran\u00e7ais D'Ophtalmologie"},{"issue":"1","key":"10.1002\/14651858.CD001211.pub3-BIB0020|cit20","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1177\/112067210901900101","article-title":"Clinical and microbiological efficacy of levofloxacin administered three times a day for the treatment of bacterial conjunctivitis","volume":"19","author":"Szaflik","year":"2009","journal-title":"European Journal of Ophthalmology"},{"issue":"5","key":"10.1002\/14651858.CD001211.pub3-BIB0021|cit21","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1177\/112067210701700501","article-title":"Prospective randomized comparison of 1-day versus 3-day application of topical levofloxacin in eliminating conjunctival flora","volume":"17","author":"Ta","year":"2007","journal-title":"European Journal of Ophthalmology"},{"key":"10.1002\/14651858.CD001211.pub3-BIB0022|cit22","unstructured":"NCT00509873 A study of the safety and efficacy of gatifloxacin in patients with bacterial conjunctivitis http:\/\/clinicaltrials.gov\/ct2\/show\/NCT00509873"},{"key":"10.1002\/14651858.CD001211.pub3-BIB0023|cit23","unstructured":"NCT00518089 A study of the safety and efficacy of gatifloxacin in patients with bacterial conjunctivitis http:\/\/clinicaltrials.gov\/ct2\/show\/NCT00518089"},{"key":"10.1002\/14651858.CD001211.pub3-BIB0024|cit24","unstructured":"NCT01175590 Safety of Besivance\u2122 (Besifloxacin ophthalmic suspension) 0.6% compared to vehicle http:\/\/clinicaltrials.gov\/ct2\/show\/NCT01175590"},{"issue":"4","key":"10.1002\/14651858.CD001211.pub3-BIB0025|cit25","first-page":"572","article-title":"A placebo-controlled clinical study of the fluoroquinolone ofloxacin in patients with external infection","volume":"31","author":"Oxfloxacin Study Group III","year":"1990","journal-title":"Investigative Ophthalmology & Visual Science"},{"key":"10.1002\/14651858.CD001211.pub3-BIB0026|cit26","doi-asserted-by":"crossref","first-page":"1477","DOI":"10.1136\/bmj.293.6560.1477","article-title":"Eye disease at a community health centre","volume":"293","author":"Dart","year":"1986","journal-title":"BMJ"},{"issue":"4","key":"10.1002\/14651858.CD001211.pub3-BIB0027|cit27","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD000023.pub3","article-title":"Antibiotics for sore throat","author":"Mar","year":"2006","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1002\/14651858.CD001211.pub3-BIB0028|cit28","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1136\/bmj.310.6989.1217","article-title":"The use of chloramphenicol as topical eye medication: time to cry halt?","volume":"310","author":"Doona","year":"1995","journal-title":"BMJ"},{"key":"10.1002\/14651858.CD001211.pub3-BIB0029|cit29","first-page":"130","article-title":"How to identify randomized controlled trials in MEDLINE: ten years on","volume":"2","author":"Glanville","journal-title":"2006"},{"issue":"1","key":"10.1002\/14651858.CD001211.pub3-BIB0030|cit30","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD000219.pub2","article-title":"Antibiotics versus placebo for acute otitis media in children","author":"Glasziou","year":"2004","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1002\/14651858.CD001211.pub3-BIB0031|cit31","unstructured":"Higgins JPT Altman DG Sterne JAC (editors) Chapter 8: Assessing risk of bias in included studies In: Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from www.cochrane-handbook.org"},{"key":"10.1002\/14651858.CD001211.pub3-BIB0032|cit32","volume-title":"Rodt oye - praktisk veiledning i allmenn praksis","author":"Hovding","year":"1991"},{"key":"10.1002\/14651858.CD001211.pub3-BIB0033|cit33","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1111\/j.1600-0420.2007.01006.x","article-title":"Acute bacterial conjunctivitis","volume":"86","author":"Hovding","year":"2008","journal-title":"Acta Ophtalmologica"},{"key":"10.1002\/14651858.CD001211.pub3-BIB0034|cit34","first-page":"962","article-title":"Topical antibiotics for acute bacterial conjunctivitis: Cochrane systematic review and meta-analysis update","volume":"55","author":"Hurwitz","year":"2005","journal-title":"British Journal of General Practice"},{"issue":"690","key":"10.1002\/14651858.CD001211.pub3-BIB0035|cit35","doi-asserted-by":"crossref","first-page":"e542","DOI":"10.3399\/bjgp11X593811","article-title":"Acute infective conjunctivitis in primary care: who needs antibiotics? An individual patient data-analysis","volume":"61","author":"Jefferis","year":"2011","journal-title":"British Journal of General Practice"},{"key":"10.1002\/14651858.CD001211.pub3-BIB0036|cit36","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/j.jfo.2010.02.001","article-title":"Efficacy of moxifloxacin in treating bacterial conjunctivitis: a meta-analysis","volume":"33","author":"Kodjikian","year":"2010","journal-title":"Journal Francais D'Ophtalmologie"},{"issue":"7132","key":"10.1002\/14651858.CD001211.pub3-BIB0037|cit37","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1136\/bmj.316.7132.667","article-title":"Risk of serious haematological toxicity with use of chloramphenicol eye drops in a British general practice database","volume":"316","author":"Lancaster","year":"1998","journal-title":"BMJ"},{"key":"10.1002\/14651858.CD001211.pub3-BIB0038|cit38","volume-title":"Morbidity statistics from general practice. Fourth national study 1991-2","author":"McCormick","year":"1995"},{"key":"10.1002\/14651858.CD001211.pub3-BIB0039|cit39","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1136\/bjo.72.10.733","article-title":"How do general practitioners manage eye disease in the community?","volume":"72","author":"McDonnell","year":"1988","journal-title":"British Journal of Ophthalmology"},{"key":"10.1002\/14651858.CD001211.pub3-BIB0040|cit40","first-page":"69","article-title":"Effectiveness, tolerability and safety of azithromycin 1% in DuraSite for acute bacterial conjunctivitis","volume":"4","author":"McLean","year":"2010","journal-title":"Patient Preference and Adherence"},{"key":"10.1002\/14651858.CD001211.pub3-BIB0041|cit41","unstructured":"The Nordic Cochrane Centre, The Cochrane Collaboration Review Manager (RevMan) 2011"},{"key":"10.1002\/14651858.CD001211.pub3-BIB0042|cit42","unstructured":"Sterne JAC Egger M Moher D (editors) Chapter 10: Addressing reporting biases In: Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Intervention. Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from www.cochrane-handbook.org"},{"issue":"9","key":"10.1002\/14651858.CD001211.pub3-BIB0043|cit43","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1016\/j.jclinepi.2005.01.006","article-title":"In an empirical evaluation of the funnel plot, researchers could not visually identify publication bias","volume":"58","author":"Terrin","year":"2005","journal-title":"Journal of Clinical Epidemiology"},{"key":"10.1002\/14651858.CD001211.pub3-BIB0044|cit44","doi-asserted-by":"crossref","first-page":"S17","DOI":"10.1097\/00006454-199702001-00005","article-title":"Conjunctivitis in infants and children","volume":"16","author":"Wald","year":"1997","journal-title":"Pediatric Infectious Diseases Journal"},{"issue":"2","key":"10.1002\/14651858.CD001211.pub3-BIB0045|cit45","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD001211","article-title":"Antibiotics for acute bacterial conjunctivitis","author":"Sheikh","year":"2000","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1002\/14651858.CD001211.pub3-BIB0046|cit46","first-page":"473","article-title":"Topical antibiotics for acute bacterial conjunctivitis: Cochrane systematic review","volume":"51","author":"Sheikh","year":"2001","journal-title":"British Journal of General Practice"},{"issue":"2","key":"10.1002\/14651858.CD001211.pub3-BIB0047|cit47","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD001211.pub2","article-title":"Antibiotics versus placebo for acute bacterial conjunctivitis","author":"Sheikh","year":"2006","journal-title":"Cochrane Database of Systematic Reviews"}],"updated-by":[{"DOI":"10.1002\/14651858.cd001211.pub4","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2023,3,13]],"date-time":"2023-03-13T00:00:00Z","timestamp":1678665600000}}],"container-title":["Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1002\/14651858.CD001211.pub3\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,8,9]],"date-time":"2021-08-09T21:00:49Z","timestamp":1628542849000},"score":1,"resource":{"primary":{"URL":"https:\/\/doi.wiley.com\/10.1002\/14651858.CD001211.pub3"}},"subtitle":[],"editor":[{"name":"Cochrane Eyes and Vision Group","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2012,9,12]]},"references-count":47,"URL":"https:\/\/doi.org\/10.1002\/14651858.cd001211.pub3","relation":{"new_version":[{"id-type":"doi","id":"10.1002\/14651858.CD001211.pub4","asserted-by":"object"}]},"ISSN":["1465-1858"],"issn-type":[{"value":"1465-1858","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,9,12]]}}}